UNSPSC 51285103: Bismuth/metronidazole/tetracycline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA303. This VA Drug Class (GA303) classifies this compound as belonging to the group H. PYLORI AGENTS.

UNSPSC 51285103 Bismuth/metronidazole/tetracycline is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The source reflects solicitations for naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies, and generic pharmaceuticals and over-the-counter products—none of which are bismuth/metronidazole/tetracycline formulations. The code shows little relevant recent activity for the pharmaceutical compound it nominally names.

The mismatch between the code's scope and the actual opportunities suggests either broad misclassification by issuing bodies or that this specific compound sees minimal state and local procurement activity. Issuers spanning county health departments (Seminole County, Florida), state HHS commissions (Texas), municipal fire departments (City of Tampa), and cooperative purchasing consortia (Minnesota MMCAP) have posted under related pharmaceutical and medical-supply codes recently, but none target the bismuth/metronidazole/tetracycline combination specified here. Firms pursuing this code should verify whether opportunities they identify are genuinely for the named compound or whether they represent routine code-tagging errors that obscure actual procurement intent.